Role of dacarbazine in the treatment of recurrent mullerian adenosarcoma with sarcomatous overgrowth: Our experience

J Obstet Gynaecol. 2016 Oct;36(7):886-887. doi: 10.3109/01443615.2016.1168373. Epub 2016 May 3.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adenosarcoma* / pathology
  • Adenosarcoma* / physiopathology
  • Adenosarcoma* / surgery
  • Aged
  • Antineoplastic Agents, Alkylating / administration & dosage
  • Biopsy / methods
  • Dacarbazine / administration & dosage*
  • Female
  • Humans
  • Hysterectomy* / adverse effects
  • Hysterectomy* / methods
  • Hysteroscopy / methods
  • Lymph Node Excision / methods*
  • Neoplasm Recurrence, Local* / diagnosis
  • Neoplasm Recurrence, Local* / drug therapy
  • Neoplasm Recurrence, Local* / pathology
  • Neoplasm Staging
  • Ovariectomy / methods*
  • Pelvis
  • Treatment Outcome
  • Ultrasonography / methods
  • Uterine Neoplasms* / pathology
  • Uterine Neoplasms* / physiopathology
  • Uterine Neoplasms* / surgery
  • Uterus / diagnostic imaging

Substances

  • Antineoplastic Agents, Alkylating
  • Dacarbazine

Supplementary concepts

  • Adenosarcoma of the uterus